Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,881 | -62,086 | -48,053 | -35,379 | -226,539 |
| Depreciation Amortization | -10,227 | -7,776 | -6,048 | -2,875 | -8,608 |
| Accounts receivable | -22,698 | -15,402 | -12,085 | -3,839 | -6,095 |
| Other Working Capital | -10,127 | -21,643 | -33,749 | -48,522 | -3,064 |
| Other Operating Activity | 79,913 | 60,100 | 44,883 | 36,931 | 149,165 |
| Operating Cash Flow | $-52,020 | $-46,807 | $-55,052 | $-53,684 | $-95,141 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 53,717 | 35,245 | 26,697 | 28,991 | -129,330 |
| PPE Investments | -1,124 | -449 | -390 | -235 | -2,168 |
| Investing Cash Flow | $52,593 | $34,796 | $26,307 | $28,756 | $-131,498 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 300,000 |
| Debt Repayment | N/A | N/A | N/A | -390 | -261,713 |
| Common Stock Issued | 3,478 | 4,059 | 1,968 | 1,692 | 8,682 |
| Other Financing Activity | -9,239 | -5,799 | -4,982 | -2,350 | -14,484 |
| Financing Cash Flow | $-5,761 | $-1,740 | $-3,014 | $-1,048 | $32,485 |
| Exchange Rate Effect | -936 | 368 | -483 | -340 | 362 |
| Beginning Cash Position | 112,447 | N/A | N/A | 112,447 | 306,239 |
| End Cash Position | 106,323 | -13,383 | -32,242 | 86,131 | 112,447 |
| Net Cash Flow | $-6,124 | $-13,383 | $-32,242 | $-26,316 | $-193,792 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,020 | -46,807 | -55,052 | -53,684 | -95,141 |
| Capital Expenditure | -1,124 | -449 | -390 | -235 | -2,168 |
| Free Cash Flow | -53,144 | -47,256 | -55,442 | -53,919 | -97,309 |